2014国际临床和转化医学论坛

Hongbin Ji

   2014-07-11
字体大小:

Hongbin Ji

Hongbin Ji is a Professor of cancer biology in Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences. He mainly focues on deciphering the molecular mechanisms involved in lung tumorigenesis with the integrative studies of mouse models and human clinical specimens. He has previously established the comprehensive spectrum of oncogenic drivers in Chinese lung cancer patients from never smokers and recently identified the RET-fusion as new driver in lung cancer. Moreover, he has found that the master kinase STK11 (LKB1) is frequently mutated in lung cancer and regulates lung cancer metastasis and the adenocarcinoma to squamous cell carcinoma transdifferentiation. He has published more than 80 papers in journals including Nature, Cancer Cell, PNAS and received many honors and rewards including China National Funds for Distinguished Young Scientists.

编辑: tong205    来源:丁香园

主办单位:

中国工程院(CAE)

中国医学科学院(CAMS)

美国国立卫生研究院临床研究中心

协办单位:

上海交通大学

复旦大学

同济大学

上海中医药大学

中国科学院上海生命科学研究院

更多详情>>

5月28日下午:高端论坛

5月28日全天:注册报到

5月29日上午:开幕式、大会报告

5月29日下午:分论坛

5月30日上午:分论坛

5月30日下午:闭幕式